Shuling Zhang

1.5k total citations
42 papers, 1.3k citations indexed

About

Shuling Zhang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Shuling Zhang has authored 42 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Immunology. Recurrent topics in Shuling Zhang's work include Natural product bioactivities and synthesis (4 papers), RNA Interference and Gene Delivery (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Shuling Zhang is often cited by papers focused on Natural product bioactivities and synthesis (4 papers), RNA Interference and Gene Delivery (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Shuling Zhang collaborates with scholars based in China, United States and Spain. Shuling Zhang's co-authors include Beverly A. Mock, Wendy Dubois, Lei Zhao, Junyan Tao, Feng Jin, John K. Simmons, Aleksandra M. Michalowski, Ji-Hua Dong, John S. Schneekloth and Ran Pang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

Shuling Zhang

38 papers receiving 1.2k citations

Peers

Countries citing papers authored by Shuling Zhang

Since Specialization

Citations

This map shows the geographic impact of Shuling Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuling Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuling Zhang more than expected).

Fields of papers citing papers by Shuling Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuling Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuling Zhang. The network helps show where Shuling Zhang may publish in the future.

Co-authorship network of co-authors of Shuling Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Shuling Zhang. A scholar is included among the top collaborators of Shuling Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuling Zhang. Shuling Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pipelines for lymphocyte homeostasis maintenance during cancer immunotherapy 2025 ·Frontiers in Immunology ·Bing Du, Jin Geng, Jingxiang Wu, (unknown), (unknown), Hanmeng Liu, Rui Zhang, Fengping Shan, Lei Liu, Shuling Zhang	0
2	Texture evolution and mechanical properties of Ti-TiAl laminated composite at different rolling temperatures 2025 ·Journal of Alloys and Compounds ·(unknown), (unknown), Ning Cui, Shuling Zhang, (unknown), Xiaopeng Wang, Fantao Kong	0
3	Discovery, engineering, and applications of the ketoreductases from Metabacillus lacus in the synthesis of chiral (Hetero)aryl alcohols 2025 ·Chemical Engineering Journal ·Shuling Zhang, Yuqing Zhang, Weixi Kong, Wei Guo, Quan Yuan, Yanjun Jiang, Yunting Liu	1
4	mTOR Modulates NLRP3 Inflammasome Activation via Nuclear Translocation and STAT1 Inhibition 2025 ·European Journal of Immunology ·Álvaro González‐Domínguez, Shuling Zhang, (unknown), Daniel A. Connors, (unknown), Beverly A. Mock, Mario D. Cordero	0
5	Oridonin attenuated human PC-3 cell activity by modulating the Wnt/β-catenin signaling 2024 ·Advances in Clinical and Experimental Medicine ·Shuling Zhang, (unknown), Lingjun Meng	0
6	The m6A modulator-mediated cytarabine sensitivity and immune cell infiltration signature in acute myeloid leukemia 2023 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Liangliang Li, Juan Cheng, (unknown), Shuling Zhang, Shan Wang, Li Zhao, (unknown)	4
7	Effects of Extracts from Saussurea laniceps on Skin Photoaging 2022 ·International Journal of Dermatology and Venereology ·Bowen Zheng, Yujie Xia, (unknown), Shuling Zhang, (unknown), (unknown)	1
8	A Small Molecule Stabilizer of the MYC G4-Quadruplex Induces Endoplasmic Reticulum Stress, Senescence and Pyroptosis in Multiple Myeloma 2020 ·Cancers ·Snehal Gaikwad, (unknown), (unknown), (unknown), David Calabrese, (unknown), Jing Huang, Aleksandra M. Michalowski, Shuling Zhang, Zheng-gang Liu, John S. Schneekloth, Beverly A. Mock	33
9	Mouse tumor susceptibility genes identify drug combinations for multiple myeloma 2020 ·Journal of Cancer Metastasis and Treatment ·Shuling Zhang, Wendy Dubois, Ke Zhang, John K. Simmons, V. Keith Hughitt, (unknown), Snehal Gaikwad, (unknown), Beverly A. Mock	3
10	Research on large scale mapping technology using three-dimensional model of UAV tilt photography 2019 ·Bulletin of Surveying and Mapping ·(unknown), Shuling Zhang, Ying Wang, (unknown)	1
11	The influence of tumor heterogeneity on sensitivity of EGFR-mutant lung adenocarcinoma cells to EGFR-TKIs 2019 ·Translational Cancer Research ·Li Sun, Yaoyong Li, (unknown), Shuling Zhang, Le‐Tian Huang, Cheng‐Bo Han	1
12	Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex 2018 ·Nature Communications ·David Calabrese, Xiang Chen, (unknown), Snehal Gaikwad, (unknown), William M. Hewitt, Stephanie Alden, Thomas A. Hilimire, Fahu He, Aleksandra M. Michalowski, John K. Simmons, Lindsey B. Saunders, Shuling Zhang, (unknown), Kylie J. Walters, Beverly A. Mock, John S. Schneekloth	137
13	Knockdown of miR-429 Attenuates Aβ-Induced Neuronal Damage by Targeting SOX2 and BCL2 in Mouse Cortical Neurons 2018 ·Neurochemical Research ·(unknown), (unknown), Shuling Zhang	10
14	Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation 2017 ·Molecular Cancer Therapeutics ·John K. Simmons, Aleksandra M. Michalowski, (unknown), Wendy Dubois, Jyoti D. Patel, Ke Zhang, Joy Gary, Shuling Zhang, Snehal Gaikwad, (unknown), Nicholas Watson, (unknown), Jin‐Qiu Chen, W. Michael Kuehl, Maxwell P. Lee, Adriana Zingone, Ola Landgren, Peter Ordentlich, Jing Huang, Beverly A. Mock	27
15	A Preclinical Systematic Review of Ginsenoside‐Rg1 in Experimental Parkinson’s Disease 2017 ·Oxidative Medicine and Cellular Longevity ·Liang Song, (unknown), Xiaoli Zhou, (unknown), Shuling Zhang, Guo‐qing Zheng	41
16	Isolation, Structure Determination, In Vivo/Vitro Assay and Docking Study of a Xanthone with antitumor activity from Fungus Penicillium oxalicum 2015 ·Records of Natural Products ·Gang Chen, Zhe Jiang, Jiao Bai, Haifeng Wang, Shuling Zhang, Yue‐Hu Pei	8
17	In vitro anti-inflammatory effects of different solution fractions of ethanol extract from Melilotus suaveolens Ledeb 2007 ·Chinese Medical Journal ·Xiaoyu Zhang, Junyan Tao, Lei Zhao, Zhijun Huang, (unknown), Shuling Zhang, Chang Ming Li, (unknown)	13
18	Growth Law of Gamma-linolenic Acid Production by Cunninghamella echinulata 2007 ·Junyan Tao, Lei Zhao, Xiaoyu Zhang, Shuling Zhang, (unknown), (unknown)	1
19	N‐Butanol Extract from Melilotus suaveolens Ledeb Affects Pro‐ and Anti‐Inflammatory Cytokines and Mediators 2007 ·Evidence-based Complementary and Alternative Medicine ·Lei Zhao, Junyan Tao, Shuling Zhang, Feng Jin, Ran Pang, Ji-Hua Dong	29
20	p16INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB 2003 ·Oncogene ·Shuling Zhang, Xiaolan Qian, (unknown), (unknown), Edward S. Ramsay, Douglas R. Lowy, Beverly A. Mock	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact